Yale Ventures
Yale Ventures is Yale University's non-profit technology transfer office, managing 1,900+ licensable technologies and five accelerator funds to commercialize faculty research. It has produced 150+ faculty spinouts and 710 startups, with $6B raised by Yale-affiliated companies in seven years.
- Company typePrivate
- Founded1982
- HeadquartersNew Haven, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Yale Ventures does
Yale Ventures is Yale University's technology transfer and innovation office, operating as a non-profit unit within the university to commercialize faculty research, support student entrepreneurship, and license university-developed intellectual property. Originally established in 1982 as the Office of Cooperative Research (OCR), the organization rebranded to Yale Ventures in 2025, expanding its mission across an ecosystem of five accelerator funds, multiple development programs, and an annual innovation summit. The organization manages access to over 1,900 licensable Yale technologies and 2,400 patents, with a portfolio that has produced 150+ faculty spinouts, 710 student and alumni startups, and $6 billion in venture funding raised by Yale-affiliated companies over the last seven years.
Yale Ventures generates revenue primarily through three mechanisms: technology licensing fees and royalties on patents licensed to external companies, equity positions in spinout companies formed from Yale research, and management of multiple accelerator funds. Major accelerator programs include the Blavatnik Fund for Innovation at Yale (over $24 million deployed since 2017 across 98 projects, resulting in 35 biotech company formations and eight clinical trials), the Roberts Innovation Fund ($500,000 created in 2022 for data-intensive domains including AI, blockchain, and trustworthy computing), and HealthTech Works (the fifth accelerator fund launched in 2026 for health technology innovation). The organization serves Yale faculty researchers, student and alumni entrepreneurs, industry partners and investors seeking to license technologies, and the broader Connecticut innovation ecosystem.
The organization's underlying platform includes IP management services, accelerator funding, mentorship programs (Entrepreneurs-in-Residence and Investors-in-Residence), customer discovery programs (NSF I-Corps), startup formation support, and ecosystem convening through the Yale Innovation Summit. Notable Yale Ventures-affiliated spinouts include Halda Therapeutics (acquired by Johnson & Johnson for $3.05 billion for its RIPTAC platform), Arvinas (with FDA-approved PROTAC therapy VEPPANU for breast cancer), Allyx Therapeutics ($62 million raised), Bexorg ($42.5 million raised), and Wavelet Medical (received ARPA-H award of up to $2.14 million for AI-powered fetal EEG monitoring). According to a LinkedIn/BCG study, Yale founders are twice as likely to found a unicorn company compared to founders from other universities, providing quantifiable evidence of the organization's founder-quality signal.
Yale Ventures firmographics
Firmographics- Name
- Yale Ventures
- Legal name
- Yale University
- Website
- https://ventures.yale.edu
- Company type
- Private
- Founded year
- 1982
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Yale Ventures is Yale University's non-profit technology transfer office, managing 1,900+ licensable technologies and five accelerator funds to commercialize faculty research. It has produced 150+ faculty spinouts and 710 startups, with $6B raised by Yale-affiliated companies in seven years.
- Ownership category
- akta.pro rank
Yale Ventures industry classification
Industry- Product category
- University Technology Transfer Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715), Management Consulting Services (54161)
- SIC
- Patent Owners & Lessors (6794), Services-Management Consulting Services (8742), Services-Engineering Services (8711)
- akta.pro primary industry
- Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)
- akta.pro secondary industries
- STEM-Focused Research Universities (Engineering & Applied Sciences) (EDAHABAB), Technical Universities with Entrepreneurship & Incubation Focus (EDAHAEAH), Technical Universities with Computing, Data & AI Focus (EDAHAEAK), Venture Capital Fundraising Placement (FSAEALAC)
Keywords
Where Yale Ventures is headquartered
LocationHeadquarters
- HQ city
- New Haven
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Yale Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Technology Licensing: Yale Ventures licenses university-developed technologies and intellectual property to external companies and startups, generating revenue through licensing fees and royalties.
- Startup Equity: Yale Ventures takes equity positions in spinout companies formed from Yale research, generating returns through exits and acquisitions.
- Accelerator Fund Management: Manages multiple accelerator funds including the Blavatnik Fund ($24M+ deployed) and Roberts Innovation Fund ($500,000), providing translational funding to faculty research.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Yale Ventures product offering
Product offeringCore offering
Yale Ventures is Yale University's technology transfer and innovation office that licenses 1,900+ university-developed technologies and 2,400 patents, manages five accelerator funds (including Blavatnik Fund and HealthTech Works) to commercialize faculty research, and supports 150+ faculty spinouts and 710 Yale-affiliated startups through mentorship, equity positions, and structured accelerator programs.
Product overview
Yale Ventures is Yale University's technology transfer and innovation office, operating as a unified platform combining multiple accelerator funds, programs, and services. The portfolio includes five accelerator funds (Blavatnik Fund, HealthTech Works, Roberts Innovation Fund, Planetary Solutions Impact Accelerator, and Colton Center for Autoimmunity), startup development programs (Venture Lab, NSF I-Corps, amplifyHERscience), major annual events (Yale Innovation Summit, Yale Lifesciences PitchFest, Startup Matchmaking), technology licensing services, and spinout companies (Wavelet Medical, EpiTet Therapeutics). The organization supports over 710 Yale startups, 150+ faculty spinouts, and manages 2,400 Yale patents with $6 billion in venture funding raised by spinouts over the last seven years.
Differentiator
Problem solved
Functional benefit
Brands
- Blavatnik Fund for Innovation at Yale: An accelerator fund that has deployed over $24 million since 2017 to support projects resulting in 35 biotech company formations and eight clinical trials.
- Roberts Innovation Fund
- HealthTech Works
- Yale Innovation Summit
- Startup Yale
- Yale Lifesciences PitchFest
Products and services
- Blavatnik Fund for Innovation at Yale An accelerator fund supporting Yale faculty research commercialization with over $24 million deployed since 2017, resulting in 35 biotech company formations and eight clinical trials.
- HealthTech Works Accelerator Health technology accelerator fund launched by Yale Ventures to support commercialization of faculty research in health technology domains.
- Roberts Innovation Fund Accelerator fund created in 2022 focusing on data-intensive domains including AI, blockchain technology, trustworthy computing, and computational modeling, providing $500,000 ($50,000 per award) to 10 faculty inventions.
- Planetary Solutions Impact Accelerator (PSIA)
Quantifiable outcome
- 35 biotech companies formed, 8 clinical trials initiated through Blavatnik Fund
- +3 more outcomes
Companies that use Yale Ventures
Customer profileNamed customers12 records
Segments4 records
Ideal customer profiles4 records
Yale Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature4 records
Yale Ventures partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- UnilevercoreUnilever announced building new U.S. research facility in New Haven - company's largest U.S. R&D infrastructure investment in decades - signaling Connecticut's rising profile as innovation destination.
- RTXcoreRTX (Raytheon) executives participated in panels at Yale Innovation Summit discussing aerospace innovation. RTX employs 16,000 people in Connecticut and spends $2.3B annually with state suppliers.
- Aegis VenturescorePartnership between Aegis Ventures and Yale spinout Wavelet Medical to develop first AI non-invasive fetal EEG monitoring platform for fetal brain monitoring.
- Tidal River FundminorYale Ventures judges participated in Tidal River Fund conference focused on alternative investments for women investors, with startup pitches featuring Yale Ventures-affiliated entrepreneurs.
- Google DeepMindminorYale and Google DeepMind collaboration on Cell2Sentence (C2S) technology for advancing AI-driven cancer therapy discovery.
- Chan Zuckerberg Initiative Biohub NYcoreYale joined Chan Zuckerberg Initiative Biohub NY with goal of bioengineering immune cells for early disease detection and prevention.
- Jubilant BiosyscoreResearch collaboration for multiple small molecule research programs where Jubilant Biosys provides medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology services to Yale investigators working on novel therapeutic targets.
Scale indicators22 records
Recent moves6 records
Expansion highlights5 records
Yale Ventures competitors and assessment
Company assessmentDirect peers
- UC Berkeley Innovation Partners: Berkeley's tech transfer and industry collaboration office. Comparable in tech-heavy IP portfolio and spinout pipeline, particularly in AI, engineering, and biotech.
- MIT Technology Licensing Office (TLO): MIT's technology transfer office, operating at a peer top-tier private research university. Manages a similarly large patent portfolio, runs accelerator programs, and has produced comparable billion-dollar spinouts in biotech and deep tech.
- Harvard Office of Technology Development (OTD): Harvard's tech transfer and commercialization office operating across Harvard's schools and hospitals. Comparable in managing a large biomedical-heavy IP portfolio and producing faculty spinouts.
- Princeton Office of Technology Licensing: Princeton's tech transfer function, also serving an Ivy League research university. Smaller portfolio but directly comparable in operating model and academic spinout focus.
- Columbia Technology Ventures: Columbia University's tech transfer office, another Ivy League peer. Manages IP licensing, runs proof-of-concept funding, and supports faculty startups in similar domains.
- Johns Hopkins Technology Ventures: Johns Hopkins' tech transfer office, particularly strong in biomedical and life sciences commercialization, making it a close functional peer in producing biotech spinouts.
- Stanford Office of Technology Licensing (OTL): Stanford's tech transfer office, the historical gold standard in university commercialization (Google, recombinant DNA). Directly comparable in scope, IP portfolio size, and biotech spinout pipeline.
- Duke Office of Licensing & Ventures: Duke's tech transfer office, similar in healthcare/biotech tilt and operating accelerator-style proof-of-concept funds for faculty innovators.
- Penn Center for Innovation: University of Pennsylvania's tech transfer and startup support office. Comparable in healthcare/biotech concentration (Penn Medicine) and accelerator programming.
- Cornell Center for Technology Licensing: Cornell's tech transfer office, another Ivy League peer institution. Manages a large patent portfolio and faculty startup pipeline with similar commercialization services.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Yale Ventures social profiles
Digital presenceYale Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Yale Ventures leadership team
Management profileNumber of profiles
Profiles5 records
Yale Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Yale Ventures M&A and investment
M&A and investmentM&A
Investments4 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Yale Ventures
What does Yale Ventures do?
Yale Ventures is Yale University's technology transfer and innovation office that licenses 1,900+ university-developed technologies and 2,400 patents, manages five accelerator funds (including Blavatnik Fund and HealthTech Works) to commercialize faculty research, and supports 150+ faculty spinouts and 710 Yale-affiliated startups through mentorship, equity positions, and structured accelerator programs.
Is Yale Ventures a public or private company?
Yale Ventures is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Yale Ventures founded?
Yale Ventures was founded in 1982. It employs 11 to 50 people.
Where is Yale Ventures based?
Yale Ventures is headquartered in New Haven, United States, in the North America region.
How does Yale Ventures make money?
Three revenue lines are on record. Technology Licensing is the primary driver. The others are startup Equity and accelerator Fund Management.
Who are Yale Ventures's main competitors?
Direct peers on record are UC Berkeley Innovation Partners, MIT Technology Licensing Office (TLO), Harvard Office of Technology Development (OTD), Princeton Office of Technology Licensing, Columbia Technology Ventures, Johns Hopkins Technology Ventures, Stanford Office of Technology Licensing (OTL), Duke Office of Licensing & Ventures, Penn Center for Innovation and Cornell Center for Technology Licensing.
Does Yale Ventures have an API?
No public API is recorded for Yale Ventures.
What industry is Yale Ventures in?
Yale Ventures's product category is University Technology Transfer Services. Its primary akta.pro industry code is EDAHABAH, Technology Transfer & Innovation-Driven Research Universities (High Commercialization), with a secondary code of EDAHABAB, STEM-Focused Research Universities (Engineering & Applied Sciences). Its NAICS code is 5417 and its SIC code is 6794.